Centyrin-siRNA Conjugates: CMC development path to Clinic
Time: 9:00 am
day: Conference Day Two
Details:
- Platform manufacturing considerations for Centyrin-siRNA conjugates
- CMC development challenges for protein-oligonucleotide conjugates
- Analytical control strategy considerations and product stability
NEW DATA
